| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H22O10 |
| Molecular Weight | 494.4469 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)[C@@H](CC1=CC(O)=C(O)C=C1)OC(=O)\C=C\C2=C(/C=C/C3=CC(O)=C(O)C=C3)C(O)=C(O)C=C2
InChI
InChIKey=YMGFTDKNIWPMGF-UCPJVGPRSA-N
InChI=1S/C26H22O10/c27-18-7-2-14(11-21(18)30)1-6-17-16(4-9-20(29)25(17)33)5-10-24(32)36-23(26(34)35)13-15-3-8-19(28)22(31)12-15/h1-12,23,27-31,33H,13H2,(H,34,35)/b6-1+,10-5+/t23-/m1/s1
| Molecular Formula | C26H22O10 |
| Molecular Weight | 494.4469 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 71.4 nM [Ki] | |||
| 39.8 nM [Ki] | |||
| 66.6 nM [Ki] | |||
| 36.2 µM [IC50] | |||
| 23.5 µM [IC50] |
